<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03007472</url>
  </required_header>
  <id_info>
    <org_study_id>CLTD5685</org_study_id>
    <nct_id>NCT03007472</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults</brief_title>
  <acronym>SME</acronym>
  <official_title>Clinical Evaluation of the Cochlear Nucleus(R) CI532 Cochlear Implant in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gather long-term data on the FDA approved CI532 cochlear
      implant, and CP1000 (Nucleus 7) sound processor
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Appropriate candidates will receive a CI532 cochlear implant and be fit with the CP1000 sound
      processor. Imaging will be completed pre-op, intra-op, and post-op to assess implant
      location. Speech perception testing as well as subjective questionnaires will be administered
      over 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To Evaluate change from pre- to 6months post-implantation speech recognition in quiet in the implanted ear alone</measure>
    <time_frame>Pre-operatively and 6 months post sound processor activation</time_frame>
    <description>Improved group mean CNC word recognition in quiet measured pre-operatively and again at 6 month post sound processor activation compared to the group mean score in the preoperative, best unilateral condition</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hearing Loss, Sensorineural</condition>
  <arm_group>
    <arm_group_label>CI532/N7 study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will receive a CI532 cochlear implant (intervention) and be fit with the CP1000 sound processor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CI532</intervention_name>
    <description>Cochlear implant</description>
    <arm_group_label>CI532/N7 study group</arm_group_label>
    <other_name>Slim Modiolar Electrode</other_name>
    <other_name>532</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nucleus 7</intervention_name>
    <description>Sound processor</description>
    <arm_group_label>CI532/N7 study group</arm_group_label>
    <other_name>N7</other_name>
    <other_name>CP1000</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adults 18 years or older who have a bilateral postlinguistic sensorineural hearing
             loss.

          2. Limited benefit from amplification as defined by test scores of 40% correct or less in
             the ear to be implanted and 50% or less in the contralateral ear on a recorded
             monosyllabic word test I. Consistent with the Minimum Speech Test Battery (2011), it
             is required that all subjects be evaluated at 60 dBA presentation level.

          3. Bilateral moderate sloping to profound hearing loss

          4. Minimum of 30 days experience with appropriately fit bilateral amplification, fit
             using the standardized NAL fitting method

          5. Proficient in English

          6. Ability to complete testing -

        Exclusion Criteria:

          1. Previous cochlear implantation

          2. Pre-linguistically deafened (onset of hearing loss at less than two years of age)

          3. Ossification or any other cochlear anomaly that might prevent complete insertion of
             the electrode array

          4. Duration of severe to profound hearing loss greater than 20 years

          5. Diagnosis of retro-cochlear pathology

          6. Diagnosis of auditory neuropathy

          7. Unrealistic expectations on the part of the subject regarding the possible benefits,
             risks, and limitations that are inherent to the surgical procedure and use of the
             prosthetic device

          8. Unwillingness or inability to comply with all investigational requirements

          9. Additional cognitive, medical or social handicaps that would prevent completion of all
             study requirements-
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jillian Crosson, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Senior Manager of Clinical Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Megan Mears, AuD</last_name>
    <role>Study Director</role>
    <affiliation>Clinical Project Manager</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Ear Center</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Center for Hearing and Balance Disorders</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Ear Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>13212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hearts for Hearing</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dallas Ear Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ear Medical Group</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spokane ENT</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Grutters JP, Joore MA, van der Horst F, Verschuure H, Dreschler WA, Anteunis LJ. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. Qual Life Res. 2007 Oct;16(8):1439-49. Epub 2007 Jul 24.</citation>
    <PMID>17647093</PMID>
  </reference>
  <reference>
    <citation>Hiller W, Goebel G. Factors influencing tinnitus loudness and annoyance. Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1323-30.</citation>
    <PMID>17178943</PMID>
  </reference>
  <reference>
    <citation>Meinert,C(1986).ClinicalTrials:Design,Conduct,andAnalysis.OxfordUniversityPress,NewYork.</citation>
  </reference>
  <reference>
    <citation>Nasreddine ZS, Phillips NA, BÃ©dirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9.</citation>
    <PMID>15817019</PMID>
  </reference>
  <reference>
    <citation>PETERSON GE, LEHISTE I. Revised CNC lists for auditory tests. J Speech Hear Disord. 1962 Feb;27:62-70.</citation>
    <PMID>14485785</PMID>
  </reference>
  <reference>
    <citation>Spahr AJ, Dorman MF, Litvak LM, Van Wie S, Gifford RH, Loizou PC, Loiselle LM, Oakes T, Cook S. Development and validation of the AzBio sentence lists. Ear Hear. 2012 Jan-Feb;33(1):112-7. doi: 10.1097/AUD.0b013e31822c2549.</citation>
    <PMID>21829134</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2016</study_first_submitted>
  <study_first_submitted_qc>December 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2017</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cochlear implant, sound processor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

